MiNK Therapeutics (INKT) Misses Q3 EPS by 65c
Tweet
Share
E-mailGet Alerts INKT Hot Sheet
Join SI Premium – FREE
MiNK Therapeutics (NASDAQ: INKT) reported Q3 EPS of ($0.65).
For earnings history and earnings-related data on MiNK Therapeutics (INKT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Upgrades 1&1 AG (1U1:GR) to Overweight
- Barclays Upgrades United Internet AG (UTDI:GR) (UDIRY) to Overweight
- Jefferies Upgrades Xylem (XYL) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
